Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry

Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry

Abstract Background The objectives of this study were to assess the discontinuation of biologic therapy in patients who achieve remission and identify predictors of discontinuation of biologics in patients with inflammatory arthritis in remission. Methods An observational retrospective study from th...

Full description

Bibliographic Details
Main Authors: Marta Valero, Carlos Sánchez-Piedra, Mercedes Freire, María Colazo, Noemí Busquets, Erardo Meriño-Ibarra, Carlos Rodríguez-Lozano, Sara Manrique, Cristina Campos, Fernando Sánchez-Alonso, Isabel Castrejón
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Arthritis Research & Therapy
Subjects:
Remission
Biologic DMARD
Discontinuation
Real-world evidence
Online Access:https://doi.org/10.1186/s13075-023-03045-3

Internet

https://doi.org/10.1186/s13075-023-03045-3

Similar Items